Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

Detalles Bibliográficos
Autores principales: Markus, Richard, Chow, Vincent, Pan, Zhiying, Hanes, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778164/
https://www.ncbi.nlm.nih.gov/pubmed/29159475
http://dx.doi.org/10.1007/s00280-017-3457-8
_version_ 1783294306905227264
author Markus, Richard
Chow, Vincent
Pan, Zhiying
Hanes, Vladimir
author_facet Markus, Richard
Chow, Vincent
Pan, Zhiying
Hanes, Vladimir
author_sort Markus, Richard
collection PubMed
description
format Online
Article
Text
id pubmed-5778164
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-57781642018-02-01 Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men Markus, Richard Chow, Vincent Pan, Zhiying Hanes, Vladimir Cancer Chemother Pharmacol Correction Springer Berlin Heidelberg 2017-11-20 2018 /pmc/articles/PMC5778164/ /pubmed/29159475 http://dx.doi.org/10.1007/s00280-017-3457-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
spellingShingle Correction
Markus, Richard
Chow, Vincent
Pan, Zhiying
Hanes, Vladimir
Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
title Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
title_full Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
title_fullStr Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
title_full_unstemmed Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
title_short Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
title_sort correction to: a phase i, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar abp 215 and bevacizumab in healthy adult men
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778164/
https://www.ncbi.nlm.nih.gov/pubmed/29159475
http://dx.doi.org/10.1007/s00280-017-3457-8
work_keys_str_mv AT markusrichard correctiontoaphaseirandomizedsingledosestudyevaluatingthepharmacokineticequivalenceofbiosimilarabp215andbevacizumabinhealthyadultmen
AT chowvincent correctiontoaphaseirandomizedsingledosestudyevaluatingthepharmacokineticequivalenceofbiosimilarabp215andbevacizumabinhealthyadultmen
AT panzhiying correctiontoaphaseirandomizedsingledosestudyevaluatingthepharmacokineticequivalenceofbiosimilarabp215andbevacizumabinhealthyadultmen
AT hanesvladimir correctiontoaphaseirandomizedsingledosestudyevaluatingthepharmacokineticequivalenceofbiosimilarabp215andbevacizumabinhealthyadultmen

Ejemplares similares